Search PubMed⌕ Search

Biomedical subjects

S G Post

Publications and source records attributed to S G Post.

66 records · Page 4Linked to original sources
PubMed1987

Family ethics in caring for newborns with impairments.

The technological advances of modern society mean that family members have expanded obligations to care for newborns with severe impairments, who would have died in previous eras. This biological imbalance has created a moral one as well, for to care is to be penalized. Often this moral heroism can be sustained as a vacation only in communities based on the ideal of Christian love. Severely impaired children impose great physical and emotional stress on their parents, which can push the parents to the limits if they are unable to tap into altruistic emotions. Historically, children were not accorded moral status in the West until the Christian influence brought them into the moral community and encouraged parental responsibility. To fulfill their obligations, perhaps parents should bring their child with impairments home and relinquish care only when they find the burden too great. They are obligated to try because they brought the child into existence (biological-causal argument), because this caring is a reflection of God's image, and because children have a moral claim on their parents. Limits to parental obligations exist when continued care would be psychologically destructive for the parents, would conflict with obligations to other family members, particularly siblings, or would be harmful to the child because the atmosphere is no longer nurturing and loving.

Congenital Abnormalities↗
PubMedDate not supplied

Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force.

There has been increasing recognition of the ethical dilemmas that arise in the delivery of health care services and in planning and executing scientific research. Alzheimer disease (AD) and related dementias pose a particular challenge for families, care providers, and researchers because of the nature of the illness. Naturally, those at potential risk of developing the disease are eager for scientists to develop valid predictive tests for the disease. Alzheimer organizations have developed worldwide in response to the growing awareness and knowledge of the effects of dementia on individuals and their families. These organizations have played a role in advocating for research, increasing general awareness of the nature of the disease, and lobbying for more services for persons with dementia and their families. These organizations have also realized the increasing concern about the many ethical issues that arise in caring for those with AD and researching causes and cures. This paper describes a unique process one national Alzheimer society used to develop an Ethics Task Force to provide guidelines on ethical issues.

Aged↗
PubMedDate not supplied

A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers.

The emergence of cognition-enhancing drugs in the treatment of Alzheimer disease raises questions about quality of lives for those with dementia and for their caregivers, and about the perceptions of health care professionals. This pilot study analyzes a limited data from a series of three focus groups on the experience of treatment. These groups engaged both Alzheimer disease-affected persons, their caregivers, and a multidisciplinary professional core. We conclude that therapeutic goals need to be better addressed with patients and families, as well as better monitored, with the possibility of withdrawing therapy as appropriate. We also detected, as hypothesized, considerable disparity between the perspectives of professionals and consumers regarding the benefits of therapy.

Aged↗